tiprankstipranks
PharmaSGP Holding SE (DE:PSG)
XETRA:PSG
Germany Market

PharmaSGP Holding SE (PSG) Financial Statements

Compare
4 Followers

PharmaSGP Holding SE Financial Overview

PharmaSGP Holding SE's market cap is currently €312.00M. The company's EPS TTM is €1.567; its P/E ratio is 16.58; and it has a dividend yield of 5.07%. PharmaSGP Holding SE is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 58.86M$ 57.04M$ 56.71M
Operating Income$ 15.49M$ 16.07M$ 24.48M
EBITDA$ 18.42M$ 14.71M$ 22.73M
Net Income$ 10.69M$ 10.64M$ 16.71M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 115.26M$ 24.94M$ 103.74M
Total Debt$ 85.19M$ 384.00K$ 254.00K
Net Debt$ 64.37M$ -7.62M$ -88.22M
Total Liabilities$ 93.06M$ 13.44M$ 8.16M
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -71.22M$ 14.56M$ 17.20M
Operating Cash Flow$ 12.24M$ 15.46M$ 17.63M
Investing Cash Flow
Financing Cash Flow
Currency in USD

PharmaSGP Holding SE Earnings and Revenue History

PharmaSGP Holding SE Debt to Assets

PharmaSGP Holding SE Cash Flow

PharmaSGP Holding SE Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis